trifluoperazine has been researched along with Porphyria, Acute Intermittent in 1 studies
Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LEE, DF | 1 |
| LUCAS, GJ | 1 |
1 other study available for trifluoperazine and Porphyria, Acute Intermittent
| Article | Year |
|---|---|
Acute intermittent porphyria treated with trifluoperazine.
Topics: Animals; Humans; Porifera; Porphyria, Acute Intermittent; Porphyrias; Tranquilizing Agents; Trifluop | 1959 |